- Featured Product
- KD/KO Validated
MAP2K3 Rekombinanter Antikörper
MAP2K3 Rekombinant Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte, Zebrafisch
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
3O10
Kat-Nr. : 80137-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
80137-1-PBS bindet in WB, IF/ICC, Indirect ELISA MAP2K3 und zeigt Reaktivität mit human, Maus, Ratten, Zebrafisch
| Getestete Reaktivität | human, Maus, Ratte, Zebrafisch |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Peptid |
| Vollständiger Name | mitogen-activated protein kinase kinase 3 |
| Berechnetes Molekulargewicht | 347 aa, 39 kDa |
| Beobachtetes Molekulargewicht | 39 kDa |
| GenBank-Zugangsnummer | BC032478 |
| Gene symbol | MAP2K3 |
| Gene ID (NCBI) | 5606 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
MAP2K3, also named MKK3, is a member of dual specificity kinase group and serves as a specific activator of p38 MAPK with MKK6. MKK3 can be phosphorylated by cytokines and environmental stress at sites Ser189 and Thr193 by MKKK proteins (MEKK 1-4). MKK3 plays a key role in cell differentiation, motility, division and death. It has been reported that MKK3 targeting may represent an effective and potentially safe therapeutic strategy to selectively kill cancer cells in colorectal cancer patients. (PMID: 31695024, 30770795, 26805700, 8622669)















